Roche in Russia Roche.com Contacts Site Map Font size home About Roche Products Research Diseases Press center RIME (For Professionals) Research Clinical researches WO29519 Participation in a clinical trial To assess your possible participation in the clinical study " Patients with Recurrent or Resistant Acute Myeloid Leukemia (AML)", you can contact one of the following institutions: City Center The address Principal Investigator Kirov FGBUN "Kirov Research Institute of Hematology and Blood Transfusion" of the Federal Medical and Biological Agency st. Krasnoarmeiskaya, 72 Minaeva Natalia Viktorovna Moscow Federal State Budgetary Institution "National Medical Research Center of Hematology" of the Ministry of Health of the Russian Federation New Zykovsky proezd, 4 Elena Nikolaevna Parovichnikova St. Petersburg State Budgetary Educational Institution of Higher Professional Education "First St. Petersburg State Medical University named after Academician I.P. Pavlov" Ministry of Health of the Russian Federation st. Lev Tolstoy d. 6-8 Afanasyev Boris Vladimirovich St. Petersburg Federal State Budgetary Institution "North-West Federal Medical Research Center named after V.A.Almazov" of the Ministry of Health of the Russian Federation st. Akkuratova, 2 Lomaia Elza Galaktionovna Printing To bookmarks Additionally on the topic Figures and facts Our strategy Our preparations Biotechnology useful links Full information about clinical trials in the Russian Federation on the website Ministry of Health of the Russian Federation, Complete information about clinical trials in the world on the website of the independent international registry of clinical trials - ClinicalTrials.gov, or on the website of the European register - Eudract Legal agreement Confidentiality © 2017 JSC "Rosh-Moscow" 03.10.2017 This website contains information for patients and specialists in the field of medicine and pharmaceuticals in Russia, and may contain information on Roche products that, for one reason or another, is not available or is not officially approved in your country. The information on this site should not be used for self-diagnosis and treatment and cannot be a substitute for an in-person consultation with a doctor.